PURPOSE: The retina is the neurosensorial tissue of the eye and is extremely rich in polyunsaturated lipid membranes. This feature makes it especially sensitive to oxygen and/or nitrogen activated species and lipid peroxidation. Several authors have postulated the importance of superoxide (O2-) and peroxynitrite production in the development of diabetic complications. In the present study, we have used two different antioxidants, ebselen and lutein, that present as a common feature their peroxynitrite scavenging capacity, to ameliorate the oxidative stress that exists in the retina in diabetic patients. METHODS: Hyperglycemia was accomplished by the intraperitoneal injection of Alloxan in a mouse model of diabetic retinopathy. Malondialdehyde (MDA) and glutathione (GSH) concentrations in eye homogenates (without the lens) were determined. We also recorded serial electroretinograms (ERG) and measured latency and implicit times. RESULTS: The MDA concentration increased and the GSH concentration decreased in the eyes of the diabetic animals. Treatment with ebselen and lutein restored the MDA and GSH concentrations to control values. Latency and implicit times were not affected by the diabetes. CONCLUSION: New studies are required to better understand the protective mechanism of ebselen and lutein in this model of experimental diabetic retinopathy.
PURPOSE: The retina is the neurosensorial tissue of the eye and is extremely rich in polyunsaturated lipid membranes. This feature makes it especially sensitive to oxygen and/or nitrogen activated species and lipid peroxidation. Several authors have postulated the importance of superoxide (O2-) and peroxynitrite production in the development of diabetic complications. In the present study, we have used two different antioxidants, ebselen and lutein, that present as a common feature their peroxynitrite scavenging capacity, to ameliorate the oxidative stress that exists in the retina in diabeticpatients. METHODS:Hyperglycemia was accomplished by the intraperitoneal injection of Alloxan in a mouse model of diabetic retinopathy. Malondialdehyde (MDA) and glutathione (GSH) concentrations in eye homogenates (without the lens) were determined. We also recorded serial electroretinograms (ERG) and measured latency and implicit times. RESULTS: The MDA concentration increased and the GSH concentration decreased in the eyes of the diabetic animals. Treatment with ebselen and lutein restored the MDA and GSH concentrations to control values. Latency and implicit times were not affected by the diabetes. CONCLUSION: New studies are required to better understand the protective mechanism of ebselen and lutein in this model of experimental diabetic retinopathy.
Authors: Siv Johnsen-Soriano; María Sancho-Tello; Emma Arnal; Amparo Navea; Enrique Cervera; Francisco Bosch-Morell; Maria Miranda; Francisco Javier Romero Journal: Graefes Arch Clin Exp Ophthalmol Date: 2010-03-06 Impact factor: 3.117
Authors: Emma Arnal; María Miranda; Inmaculada Almansa; María Muriach; Jorge M Barcia; Francisco J Romero; Manuel Diaz-Llopis; Francisco Bosch-Morell Journal: Graefes Arch Clin Exp Ophthalmol Date: 2008-09-03 Impact factor: 3.117
Authors: Orhan Ates; Habip Bilen; Sadullah Keles; H Hakan Alp; Mevlüt Sait Keleş; Kenan Yıldırım; Osman Ondaş; L Can Pınar; Mustafa Civelekler; Orhan Baykal Journal: Int J Ophthalmol Date: 2013-10-18 Impact factor: 1.779
Authors: Adolfo Daniel Rodríguez-Carrizalez; José Alberto Castellanos-González; Esaú César Martínez-Romero; Guillermo Miller-Arrevillaga; Luis Miguel Román-Pintos; Fermín Paul Pacheco-Moisés; Alejandra Guillermina Miranda-Díaz Journal: Redox Rep Date: 2016-02-05 Impact factor: 4.412